$7.36 Billion is the total value of Matrix Capital Management Company, LP's 17 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 11.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVDA | Buy | NVIDIA CORPORATION | $1,504,013,442 | +102.9% | 5,414,600 | +6.7% | 20.43% | +44.3% |
| Sell | GLOBALFOUNDRIES INCordinary shares | $1,288,268,640 | +29.2% | 17,848,000 | -3.5% | 17.50% | -8.1% | |
| TDG | TRANSDIGM GROUP INC | $806,996,045 | +17.1% | 1,094,900 | 0.0% | 10.96% | -16.7% | |
| ALTR | Buy | ALTAIR ENGR INC | $805,771,562 | +63.0% | 11,174,200 | +2.8% | 10.94% | +16.0% |
| AMAT | Buy | APPLIED MATLS INC | $773,546,491 | +86.1% | 6,297,700 | +47.5% | 10.51% | +32.4% |
| AMZN | Buy | AMAZON COM INC | $757,717,674 | +77.4% | 7,335,828 | +44.3% | 10.29% | +26.2% |
| ASML | ASML HOLDING N V | $338,449,012 | +24.6% | 497,200 | 0.0% | 4.60% | -11.4% | |
| WDAY | WORKDAY INCcl a | $327,581,321 | +23.4% | 1,586,043 | 0.0% | 4.45% | -12.2% | |
| SNPS | New | SYNOPSYS INC | $235,510,144 | – | 609,735 | +100.0% | 3.20% | – |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $158,239,536 | -14.6% | 9,199,973 | 0.0% | 2.15% | -39.2% | |
| XLE | Buy | SELECT SECTOR SPDR TRenergy | $106,188,060 | +247.5% | 1,282,000 | +266.9% | 1.44% | +147.3% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $102,185,970 | +15.6% | 11,572,590 | 0.0% | 1.39% | -17.8% | |
| PERIMETER SOLUTIONS SA | $60,297,000 | -11.6% | 7,462,500 | 0.0% | 0.82% | -37.1% | ||
| AURA BIOSCIENCES INC | $49,767,434 | -11.6% | 5,362,870 | 0.0% | 0.68% | -37.1% | ||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $42,481,862 | -25.3% | 38,974,185 | 0.0% | 0.58% | -46.9% | |
| Sell | VENTYX BIOSCIENCES INC | $3,011,650 | -72.6% | 89,900 | -73.2% | 0.04% | -80.5% | |
| ZS | Sell | ZSCALER INC | $2,150,256 | -97.0% | 18,405 | -97.2% | 0.03% | -97.9% |
| QCOM | Exit | QUALCOMM INC | $0 | – | -3,337,360 | -100.0% | -7.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 42 | Q3 2023 | 13.3% |
| WORKDAY INC | 42 | Q3 2023 | 19.7% |
| NETFLIX INC | 37 | Q2 2022 | 26.1% |
| NEW RELIC INC | 29 | Q1 2022 | 7.8% |
| DAVITA INC | 26 | Q3 2019 | 6.1% |
| ADAPTIMMUNE THERAPEUTICS PLC | 26 | Q3 2023 | 6.8% |
| SALESFORCE INC | 23 | Q3 2022 | 18.4% |
| CONSTELLATION BRANDS INC | 23 | Q2 2019 | 5.7% |
| AMAZON COM INC | 21 | Q3 2023 | 11.2% |
| TABLEAU SOFTWARE INC | 20 | Q2 2019 | 15.2% |
View Matrix Capital Management Company, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | July 10, 2023 | 233,845,110 | 17.3% |
| Zentalis Pharmaceuticals, Inc. | June 20, 2023 | 13,959,973 | 19.8% |
| ForgeRock, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| NEW RELIC, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Perimeter Solutions, SA | February 13, 2023 | 8,587,500 | 5.4% |
| Aura Biosciences, Inc. | December 07, 2022 | 5,362,870 | 14.5% |
| Adaptive Biotechnologies Corp | February 14, 2022 | 11,572,590 | 8.2% |
| BigCommerce Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| CarGurus, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Trillium Therapeutics Inc.Sold out | February 14, 2020 | 0 | 0.0% |
View Matrix Capital Management Company, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-09 |
| SC 13D/A | 2023-11-09 |
| 13F-HR | 2023-08-14 |
| SC 13G/A | 2023-07-10 |
| 4 | 2023-06-20 |
| SC 13D/A | 2023-06-20 |
| 13F-HR | 2023-05-15 |
View Matrix Capital Management Company, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.